A 27-year-old patient came in with history of swelling in the neck on the right side.
A 27-year-old patient came in with history of swelling in the neck on the right side. Ultrasound scan showed enlarged diffusely hypoechoic right lobe of thyroid with increased vascularity. Left lobe and isthmus were absent. No previous history of hemithyroidectomy. Thyroid function tests showed hyperthyroidism.
Figure 1: Absent left lobe of thyroid and isthmus
Figure 2: Absent left lobe of thyroid and isthmus
Figure 3: Enlarged diffusely hypoechoic right lobe
Figure 4: Right thyroid lobe with increased vascularity
Figure 5: Right thyroid lobe with increased vascularity
Discussion: Hemithyroid agenesis is a rare congenital anomaly of thyroid has found to be three times more common in females as compared to males. In 80 percent, the left thyroid lobe is absent and about 50 percent of patients with left hemithyroid agenesis will also have an absent thyroid isthmus.
Many times, the patient is found to have hemiagenesis of a thyroid lobe incidentally. Coexisting thyroid disorders in the remaining lobe are a common occurrence with hemiagenesis.
Disorders that haven reported in the remnant thyroid lobe include hyperthyroidism, hypothyroidism, multinodular goiter, chronic thyroiditis, adenocarcinoma, and papillary thyroid carcinoma. Hyperthyroidism is the most prevalent disorder associated with thyroid hemiagenesis. In fact, many cases of hemiagenesis discovered upon workup of the hyperthyroidism.
Harpreet Singh, MD, JP Scan private diagnostic center, Khanna, Punjab, India
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.